Franklin Resources’s IVERIC bio, Inc. Common Stock ISEE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q3
Sell
-57,039
Closed -$2.24M 2845
2023
Q2
$2.24M Sell
57,039
-1,664,759
-97% -$58.8M ﹤0.01% 1369
2023
Q1
$41.9M Buy
1,721,798
+10,895
+0.6% +$239K 0.02% 575
2022
Q4
$36.6M Sell
1,710,903
-531
-0% -$11.3K 0.02% 609
2022
Q3
$30.7M Buy
1,711,434
+482,934
+39% +$6.34M 0.02% 666
2022
Q2
$11.8M Buy
1,228,500
+732
+0.1% +$9.19K 0.01% 912
2022
Q1
$20.7M Sell
1,227,768
-1,825
-0.1% -$27K 0.01% 849
2021
Q4
$20.6M Buy
1,229,593
+1,122,461
+1,048% +$18.4M 0.01% 884
2021
Q3
$1.74M Buy
+107,132
New +$1.17M ﹤0.01% 1494
2016
Q4
Sell
-805,586
Closed -$37.2M 1528
2016
Q3
$37.2M Sell
805,586
-343
-0% -$19.3K 0.02% 619
2016
Q2
$41.1M Buy
805,929
+218,227
+37% +$10.8M 0.02% 586
2016
Q1
$24.8M Buy
587,702
+80,930
+16% +$4.12M 0.01% 756
2015
Q4
$39.8M Sell
506,772
-65,200
-11% -$3.77M 0.02% 624
2015
Q3
$23.2M Buy
571,972
+343,225
+150% +$18.2M 0.01% 802
2015
Q2
$11.9M Buy
228,747
+9,089
+4% +$452K 0.01% 1001
2015
Q1
$10.2M Buy
219,658
+152,846
+229% +$7.93M ﹤0.01% 1048
2014
Q4
$3M Buy
+66,812
New +$2.81M ﹤0.01% 1264

Franklin Resources's ISEE Position: Q3 2023 in Review

Franklin Resources sold out of IVERIC bio, Inc. Common Stock (ISEE) in Q3 2023, closing a stake of 57,039 shares — an estimated $2.24M sold.

Franklin Resources first reported a position in ISEE in Q4 2014 and held it in 16 quarters. The position peaked at $41.9M in Q1 2023. 0 funds tracked by Wall St. Rank hold ISEE as of Q3 2023.

  • Franklin Resources reported no remaining IVERIC bio, Inc. Common Stock position as of Q3 2023 after selling out during the quarter.
  • Franklin Resources sold 57,039 IVERIC bio, Inc. Common Stock shares in Q3 2023, an estimated $2.24M.
  • Franklin Resources first reported a position in IVERIC bio, Inc. Common Stock in Q4 2014 and held it in 16 quarters.
  • Franklin Resources's IVERIC bio, Inc. Common Stock position peaked at $41.9M in Q1 2023.
  • 0 funds tracked by Wall St. Rank held IVERIC bio, Inc. Common Stock as of Q3 2023.

Based on Franklin Resources's 13F filing for Q3 2023, filed 13 Nov 2023.